PCN69 - BUDGET IMPACT OF SUBSTITUTING BIOSIMILAR TRASTUZUMAB (CT-P6) IN TREATING GASTRIC CANCER AND BREAST CANCER IN 28 EUROPEAN COUNTRIES
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.151
https://www.valueinhealthjournal.com/article/S1098-3015(18)33451-X/fulltext
Title :
PCN69 - BUDGET IMPACT OF SUBSTITUTING BIOSIMILAR TRASTUZUMAB (CT-P6) IN TREATING GASTRIC CANCER AND BREAST CANCER IN 28 EUROPEAN COUNTRIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33451-X&doi=10.1016/j.jval.2018.09.151
First page :
Section Title :
Open access? :
No
Section Order :
869